Your browser doesn't support javascript.
loading
Diabetes mellitus por mutación en el gen de glucokinasa: caso clínico / Diabetes mellitus caused by a mutation of glucokinase gene: report of an affected family
Pollak C, Felipe; Lagos L, Marcela; Santos M, José L; Poggi, Helena; Urzúa C, Abraham; Rumié C, Hana.
  • Pollak C, Felipe; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Nutrición, Diabetes y Metabolismo. Santiago. CL
  • Lagos L, Marcela; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Nutrición, Diabetes y Metabolismo. Santiago. CL
  • Santos M, José L; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Nutrición, Diabetes y Metabolismo. Santiago. CL
  • Poggi, Helena; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Nutrición, Diabetes y Metabolismo. Santiago. CL
  • Urzúa C, Abraham; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Nutrición, Diabetes y Metabolismo. Santiago. CL
  • Rumié C, Hana; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Nutrición, Diabetes y Metabolismo. Santiago. CL
Rev. méd. Chile ; 145(9): 1203-1207, set. 2017. tab, graf
Article in Spanish | LILACS | ID: biblio-902608
ABSTRACT
Maturity-Onset Diabetes of the Young (MODY) refers to a heterogeneous group of monogenic diabetes. Unlike other types of MODY characterized by genetic defects in transcription factors, MODY 2 is triggered by metabolic alterations caused by mutations of glucokinase (GCK), the first enzyme of the glycolytic pathway. We report a three-generation Chilean family with multiple cases affected with this disease. The index case is a patient who presented severe neonatal hyperglycemia (831 mg/dl, without ketosis) requiring continuous infusion of insulin, which was suspended after 48 hours with normalization of blood glucose. Subsequently, continuous glucose monitoring at 4 months of age revealed 47% of tissue glucose levels above 140 mg/dl, with fasting glucose levels between 120 and 166 mg/dl. The genetic analysis revealed a previously reported mutation in heterozygous state of the GCK gene (c.148C>T; p.His50Tyr). This mutation was also identified in more than one affected relative in the last two generations, with a transmission pattern suggestive of dominant inheritance. GCK gene sequencing led to a correct molecular diagnosis of MODY 2 while bioinformatic analysis indicated the possible molecular causes of the enzyme dysfunction. The knowledge of the molecular diagnosis allowed an adequate medical treatment for this disease.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Diabetes Mellitus, Type 2 / Glucokinase / Mutation Type of study: Observational study / Prognostic study Limits: Humans / Male / Infant, Newborn Language: Spanish Journal: Rev. méd. Chile Journal subject: Medicine Year: 2017 Type: Article Affiliation country: Chile Institution/Affiliation country: Pontificia Universidad Católica de Chile/CL

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Diabetes Mellitus, Type 2 / Glucokinase / Mutation Type of study: Observational study / Prognostic study Limits: Humans / Male / Infant, Newborn Language: Spanish Journal: Rev. méd. Chile Journal subject: Medicine Year: 2017 Type: Article Affiliation country: Chile Institution/Affiliation country: Pontificia Universidad Católica de Chile/CL